20021020
 Business Brief -- Amgen Inc.: Minor Victory Is Obtained Against Johnson & Johnson   The Wall Street Journal,  Oct 21, 2002  Amgen Inc. eked out a minor victory against rival Johnson & Johnson in binding arbitration, winning $150 million in damages but failing to overturn a 1985 marketing agreement restricting its ability to sell its anemia drug Epogen.   
